Fig. 3From: Efficacy and safety of low-dose corticosteroids combined with leflunomide for progressive IgA nephropathy: a systematic review and meta-analysisForest plots showing changes in: A Serious adverse events; B Respiratory infection; C Abnormal liver function; D Diarrhea; E, Herpes zoster; F Alopecia; G Urinary tract infectionBack to article page